Perspective Therapeutics (CATX) Revenue (2010 - 2023)

Perspective Therapeutics' Revenue history runs 14 years deep, the most recent figure standing at -$4.9 million for Q4 2023.

• In Q4 2023, Revenue changed N/A year-over-year to -$4.9 million; the TTM figure through Dec 2023 stood at $613000.0 (changed N/A YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
• Revenue came in at -$4.9 million for Q4 2023 at Perspective Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.9 million in Q1 2022 to a low of -$4.9 million in Q4 2023.
• A 5-year average of $1.9 million and a median of $2.3 million in 2019 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 49.69% in 2020 and tumbled 40.12% in 2023, its largest moves.
• Perspective Therapeutics' Revenue stood at $2.2 million in 2019, then climbed by 6.94% to $2.4 million in 2020, then rose by 19.37% to $2.8 million in 2021, then slumped by 39.03% to $1.7 million in 2022, then plunged by 385.5% to -$4.9 million in 2023.
• According to Business Quant data, Revenue over the past three periods registered -$4.9 million, $2.2 million, and $1.5 million for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison